AI Summary
Thinking
Thinking
We reviewed 1,729 live results for xembify immune globulin subcutaneous human klhw 20 and narrowed them down to the 3 options that look most worth comparing first.
The options are XEMBIFY® (immune globulin subcutaneous, human–klhw) 20%, Xembify and Hizentra (Immune Globulin Subcutaneous [Human] 20% Liquid).
Source: Xembify
Description
XEMBIFY is a sterile, 20% liquid solution of human immune globulin G (IgG) indicated for the treatment of primary humoral immunodeficiency (PI) in adults and pediatric patients 2 years of age and older. This subcutaneous immune globulin (SCIG) replacement therapy is available in single-use glass vials in multiple sizes, including 1 g, 2 g, 4 g, and 10 g, to accommodate flexible dosing requirements and home administration.
Best for
primary humoral immunodeficiency treatment, patients 2 years and older, subcutaneous infusion therapy and home self-administration
Rate this product
Source: Grifols
Description
Xembify is a 20% liquid SCIG indicated for Primary Humoral Immunodeficiency (PI) in patients 2 years and older. It is formulated as a highly purified IgG solution (at least 98% IgG).
Best for
PI patients, high purity requirements, pediatric patients and SCIG therapy
Rate this product
Source: CSL Behring
Description
Hizentra is the first and only 20% subcutaneous immunoglobulin (SCIg) therapy approved for the treatment of primary immunodeficiency (PI) and the maintenance treatment of chronic inflammatory demyelinating polyneuropathy (CIDP). This human normal immunoglobulin solution is stabilized with L-proline and designed for convenient subcutaneous injection, allowing for patient self-administration at home with single-dose prefilled syringes or vials.
Best for
primary immunodeficiency patients, CIDP maintenance therapy, subcutaneous self-administration and home-based medical treatment
Rate this product
| Compare | #1XEMBIFY® (immune globulin subcutaneous, human–klhw) 20% | #2Xembify | #3Hizentra (Immune Globulin Subcutaneous [Human] 20% Liquid) |
|---|---|---|---|
| Source | Xembify | Grifols | CSL Behring |
| Description | XEMBIFY is a sterile, 20% liquid solution of human immune globulin G (IgG) indicated for the treatment of primary humoral immunodeficiency (PI) in adults and pediatric patients 2 years of age and older. This subcutaneous immune globulin (SCIG) replacement therapy is available in single-use glass vials in multiple sizes, including 1 g, 2 g, 4 g, and 10 g, to accommodate flexible dosing requirements and home administration. | Xembify is a 20% liquid SCIG indicated for Primary Humoral Immunodeficiency (PI) in patients 2 years and older. It is formulated as a highly purified IgG solution (at least 98% IgG). | Hizentra is the first and only 20% subcutaneous immunoglobulin (SCIg) therapy approved for the treatment of primary immunodeficiency (PI) and the maintenance treatment of chronic inflammatory demyelinating polyneuropathy (CIDP). This human normal immunoglobulin solution is stabilized with L-proline and designed for convenient subcutaneous injection, allowing for patient self-administration at home with single-dose prefilled syringes or vials. |
| Best for | primary humoral immunodeficiency treatment, patients 2 years and older, subcutaneous infusion therapy and home self-administration | PI patients, high purity requirements, pediatric patients and SCIG therapy | primary immunodeficiency patients, CIDP maintenance therapy, subcutaneous self-administration and home-based medical treatment |
| Action | Xembify | Grifols | CSL Behring |
| Rate this product |
"XEMBIFY® (immune globulin subcutaneous, human–klhw) 20% from Xembify."
TopFind picked this because Xembify provides a high-concentration 20% IgG solution with multiple vial size options, making it a versatile choice for patients seeking subcutaneous therapy for primary immunodeficiency.
Note: TopFind AI compiles product and service information for general comparison purposes only.